The 32 references in paper Y. Fedotkina A., E. Panchenko P., Ю. Федоткина А., Е. Панченко П. (2017) “ТРОМБОЗЫ В ОНКОЛОГИИ. ЧАСТЬ 1 // THROMBOSES IN ONCOLOGY. PART 1” / spz:neicon:aterotromboz:y:2017:i:1:p:11-15

1
Green KB, Silverstein RL. Hypercoagulobil-ity in cancer. Hemat. Onc. Clin. N. Am., 1996, 10: 499-530.
(check this in PDF content)
2
Hillen HF. Thrombosis in cancer patients. ESMO Ann. Oncol., 2000, 11(Suppl. 3): 273-6.
(check this in PDF content)
3
Levine MN, Lee AY, Kakkar AK. Thrombosis and cancer. American Society of Clinical Oncology, 41 Annual Meeting, May 13-17, 2005: 748-777.
(check this in PDF content)
4
Bromberg ME, Cappello M. Cancer and blood coagulation: molecular aspects. Cancer,1999, 3: 132-8.
(check this in PDF content)
5
Falanga A, Tickles FR. Pathophysiology of the thrombotic state in the cancer patient. Semin. Thromb. Haemostas., 1999, 25: 173-82.
(check this in PDF content)
6
Сомонова О. Маджуга А., Елизарова А. Тромбозы и тромбоэмболии в онкологии. Современный взгляд на проблему. Злокачественные опухоли, 2014, 3(10).
(check this in PDF content)
7
Bauer KA, Levine M. Evaluation and management of the cancer patient with thrombosis. Am. Soc. Clin. Oncol., 1999: 223-35.
(check this in PDF content)
8
Loreto MF, Martinis DE, Corsi MP. Coagulation and cancer: implications for diagnosis and management. Pathol. АРТЕРИАЛЬНЫЕ И ВЕНОЗНЫЕ ТРОМБОЗЫ Oncol. Res.,2000, 6(4): 302-12.
(check this in PDF content)
9
Rickles F, Falanga A. A Molecular basis for the relationship between thrombosis and cancer. Thromb. Res., 2001,
(check this in PDF content)
10
215-24. 10. Prandoni P, Piccioli A, Girolami A. Cancer and venous thromboembolism: an overview. Hematologica, 1999, 84: 437-45.
(check this in PDF content)
11
Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ. Cancer and venous thromboembolism. Am. Heart J, 1996, 132: 850-5.
(check this in PDF content)
12
Agnelii G. Venous thromboembolism and cancer: twoway clinical association. Thromb. Haemost., 1997, 78(1): 117-20.
(check this in PDF content)
13
Donati MB. Cancer and thrombosis. Haemostasis,1994, 24: 128-31.
(check this in PDF content)
14
Levine MN. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb. Haemost., 1997, 78: 133-6.
(check this in PDF content)
15
Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncology,2011, 29: 3466-3473.
(check this in PDF content)
16
Zamorano JL, Lancellotti P, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicitr developed under the auspices of the ESC Committee for Practice Guidelines. EHJ. doi:10.1093/eurheat/ehw 211.
(check this in PDF content)
17
Haugnes HS, Wethal T, AassN, et al. Cardiovascular risk factors and morbidity in long-term survivors of testricular cancer: a 20-year follow-up study. J Clin. Oncology, 2010, 28: 4649-4657.
(check this in PDF content)
18
Huddart RA, Norman A, Shahidi M, et al. Cardiovascular disease as long-termcomplication of treatment for testicular cancer. J Clin Oncology, 2003, 21: 1513-1523.
(check this in PDF content)
19
Cameron D, Brown J, Dent R, et al. Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomized, phase 3 trial. Lancet Oncol, 2013, 14: 933-942.
(check this in PDF content)
20
Huddart RA, Norman A, Shahidi M, et al. Cardiovascular disease as long-termcomplication of treatment for testicular cancer. J Clin Oncology,2003, 21: 1513-1523.
(check this in PDF content)
21
McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, Fornander T, Gigante B, Jensen MB, Peto R, Rahimi K, TaylorCW, Ewertz M. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol,2011, 100: 167-175.
(check this in PDF content)
22
Virmani R, Farb A, Carter AJ, Jones RM. Comparative pathology: radiation-induced coronary artery disease in man and animals. Semin Interv Cardiol,1998, 3: 163-172.
(check this in PDF content)
23
Brosius FC, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med,1981, 70: 519-530.
(check this in PDF content)
24
Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol, 1996, 27: 766-773.
(check this in PDF content)
25
McEniery PT, Dorosti K, Schiavone WA, Pedrick TJ, Sheldon WC. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol, 1987, 60: 1020-1024.
(check this in PDF content)
26
King V, Constine LS, Clark D, Schwartz RG, Muhs AG, Henzler M, Hutson A, Rubin P. Symptomatic coronary artery disease after mantle irradiation for Hodgkin’s disease. Int J Radiat Oncol Biol Phys, 1996, 36: 881-889.
(check this in PDF content)
27
Darby SC, Ewertz M, McGale P, Bennet AM, BlomGoldman U, Bronnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med,2013, 368: 987-998.
(check this in PDF content)
28
Storey MR, Munden R, Strom EA, McNeese MD, Buchholz TA. Coronary arterydosimetry in intact left breast irradiation. Cancer J, 2001, 7: 492-497.
(check this in PDF content)
29
Windecker S, Kolh P, Alfonso F, et.al 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J, 2014, 35: 2541-2619.
(check this in PDF content)
30
Roffi M, Patrono C, Collet JP, Mueller C, Luis Zamorano J et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J, 2016, 37: 267-315.
(check this in PDF content)
31
Steg PG, James SK, Atar D, Badano LP, et. al Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC),ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J, 2012, 33: 2569-2619.
(check this in PDF content)
32
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. Circulation, 2016, 134: e123-e155. DOI: 10.1161/CIR.0000000000000404.
(check this in PDF content)